[CLINICAL TESTING OF THE THERAPEUTIC EFFECT OF 1,6-BIS(2-MESYLOXYETHYLAMINO) 1,6-DIDESOXY-D-MANNITOL DI-HC1 (R 49)].
D000970:Antineoplastic Agents; D001772:Blood Cell Count; D001792:Blood Platelets; D006689:Hodgkin Disease; D007938:Leukemia; D007945:Leukemia, Lymphoid; D007970:Leukopenia; D008199:Lymphadenitis; D008223:Lymphoma; D016403:Lymphoma, Large B-Cell, Diffuse; D008228:Lymphoma, Non-Hodgkin; D008353:Mannitol; D008357:Mannomustine; D009369:Neoplasms; D013902:Radiography, Thoracic; D012509:Sarcoma; D013921:Thrombocytopenia; D014116:Toxicology
D000970:Antineoplastic Agents; D008353:Mannitol; D008357:Mannomustine
ANTINEOPLASTIC AGENTS; BLOOD CELL COUNT; BLOOD PLATELETS; HODGKIN'S DISEASE; LEUKEMIA, LYMPHOCYTIC; LEUKOPENIA; LYMPHADENITIS; LYMPHOSARCOMA; MANNOMUSTINE; SARCOMA, RETICULUM CELL; THORACIC RADIOGRAPHY; THROMBOPENIA; TOXICOLOGIC REPORT
AZ 1,6-BIS(BETA-MESILOXY-AETHYLAMINO)-1,6-DIDESOXY-D-MANNIT DICHLORHYDRAT (R 49) THERAPI'AS HAT'AS'ANAK KLINIKAI VIZSG'ALATA.